NRx Pharmaceuticals, Inc. (NRXP)

NRx Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-30.16	-39.75	-348.89	-51.78	-6.73
Depreciation & Amortization	0.01	0	0	0	0
Share-Based Compensation	0.39	3.63	61.62	0.73	0.93
Other Operating Activities	8.1	-3.63	-6.26	48.78	0.25
Operating Cash Flow	-21.66	-39.76	-37.7	-2.27	-5.54
Capital Expenditures	-0	-0.01	-0.01	-0	-0
Investing Cash Flow	-0	-0.01	-0.01	-0	-0
Share Issuance / Repurchase	8.12	22.71	64.73	2.58	5.8
Debt Issued / Paid	-3.09	9.5	-1.28	0.62	0
Other Financing Activities	1.17	-	-	0.05	-
Financing Cash Flow	6.2	32.21	63.46	3.25	5.8
Net Cash Flow	-15.46	-7.55	25.75	0.98	0.26
Free Cash Flow	-21.66	-39.77	-37.71	-2.27	-5.55
Free Cash Flow Per Share	-2.86	-6.05	-8.04	-0.66	-5.19

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).